GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Intellia Therapeutics

NTLA 13.07 +3.73%

Close of 9 October 2026, in USD — never converted.

Intellia Therapeutics — daily NTLA Delayed

Chart and prices are provided by TradingView. Global Banking & Finance Review publishes no price data on this page. Nothing here is investment advice. How we cover markets.

Frequently asked questions

What is Intellia Therapeutics's ticker?

Intellia Therapeutics trades as NTLA on its US listing, under ISIN US45826J1051.

What was Intellia Therapeutics's last closing price?

13.07 on 9 October 2026. The figure is in USD and is never converted.

Does Global Banking & Finance Review publish price data for Intellia Therapeutics?

We publish the closing prices we record ourselves, in the currency the instrument trades in. Charts and live quotes come from TradingView. Nothing on this page is investment advice.